Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

26. April 2025 14:00 ET | Quelle: Janssen Cilag International NV

Johnson & Johnson’s TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC

First results from SunRISe-1 (Cohort 4) show strong disease-free survival rates across high-grade papillary tumours, demonstrating the potential for bladder preservation with 94 percent of patients...
26. April 2025 13:50 ET | Quelle: Janssen Cilag International NV

Johnson & Johnson’s TAR-200 monotherapy demonstrates highest complete response rate reported to date with sustained clinical benefits in patients with certain types of bladder cancer

Phase 2b SunRISe-1 study shows more than 82 percent of patients achieved complete response (CR) with more than half of responders remaining cancer-free at one year after CR1 Results reinforce...
25. April 2025 03:00 ET | Quelle: Janssen Cilag International NV

TREMFYA® (guselkumab) receives European Commission approval for adults with moderately to severely active ulcerative colitis, strengthening Johnson & Johnson’s leadership in inflammatory bowel disease

The firsta approved fully-human, dual-acting interleukin-23 (IL-23) inhibitor in moderately to severely active ulcerative colitis,1,2,3,4,5 guselkumab showed statistically higher rates of endoscopic...
24. April 2025 04:14 ET | Quelle: Foresight Enterprise VCT plc.

Final Results

FORESIGHT ENTERPRISE VCT PLC LEI: 213800MWJNR3WZZ3ZP42 24 April 2025 Final results31 December 2024 Foresight Enterprise VCT plc, managed by Foresight Group LLP, today announces the final results...
18. April 2025 09:17 ET | Quelle: Research and Markets

Effective Management of Supply Chain Risk Training Course (ONLINE EVENT: June 9-10, 2025)

Dublin, April 18, 2025 (GLOBE NEWSWIRE) -- The "Effective Management of Supply Chain Risk Training Course" training has been added to ResearchAndMarkets.com's offering. This course will give...
16. April 2025 06:33 ET | Quelle: Foresight VCT PLC

Final Results

FORESIGHT VCT PLCLEI: 213800GNTY699WHACF4616 April 2025 Final results31 December 2024 Foresight VCT plc, managed by Foresight Group LLP, today announces the final results for the year ended 31...
15. April 2025 11:00 ET | Quelle: Precedence Research

3D Printing Market Size to Exceed USD 134.58 Billion by 2034

Ottawa, April 15, 2025 (GLOBE NEWSWIRE) -- According to Precedence Research, the 3D printing market size is expected to grow from USD 24.61 billion in 2024 to USD 29.29 billion in 2025, and...
08. April 2025 05:38 ET | Quelle: Janssen Cilag International NV

Johnson & Johnson highlights new data, demonstrating long-term sustained disease control in adults living with generalised myasthenia gravis (gMG)

New compelling results demonstrate 18 months of both sustained reduction in immunoglobulin G antibodies and sustained improvement in gMG symptoms in pivotal Vivacity-MG3 study and open label extension...
08. April 2025 03:30 ET | Quelle: Janssen Cilag International NV

Johnson & Johnson highlights new data, demonstrating long-term sustained disease control in adults living with generalised myasthenia gravis (gMG)

New compelling results demonstrate 18 months of both sustained reduction in immunoglobulin G antibodies and sustained improvement in gMG symptoms in pivotal Vivacity-MG3 study and open label extension...
07. April 2025 10:33 ET | Quelle: Research and Markets

Growth Trends, Competitive Strategies and Forecasts 2025-2033: Advancements in Additive Manufacturing, Growing Demand in Automotive and Aerospace, High Initial Investments

Dublin, April 07, 2025 (GLOBE NEWSWIRE) -- The "Powder Metallurgy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts,...

Vorherige Seite

Nächste Seite